Exclusive

Publication

Byline

Location

NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: CENTER FOR SCIENTIFIC REVIEW; AMENDED NOTICE OF MEETING

WASHINGTON, May 21 -- National Institutes of Health has issued a notice called: Center for Scientific Review; Amended Notice of Meeting. The notice was published in the Federal Register on May 21 by ... Read More


NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: CENTER FOR SCIENTIFIC REVIEW; AMENDED NOTICE OF MEETING

WASHINGTON, May 21 -- National Institutes of Health has issued a notice called: Center for Scientific Review; Amended Notice of Meeting. The notice was published in the Federal Register on May 21 by ... Read More


NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: CENTER FOR SCIENTIFIC REVIEW; AMENDED NOTICE OF MEETING

WASHINGTON, May 21 -- National Institutes of Health has issued a notice called: Center for Scientific Review; Amended Notice of Meeting. The notice was published in the Federal Register on May 21 by ... Read More


NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: CENTER FOR SCIENTIFIC REVIEW; NOTICE OF CLOSED MEETINGS

WASHINGTON, May 21 -- National Institutes of Health has issued a notice called: Center for Scientific Review; Notice of Closed Meetings. The notice was published in the Federal Register on May 21 by ... Read More


DEPARTMENT OF HEALTH AND HUMAN SERVICES ISSUES NOTICE: AGENCY INFORMATION COLLECTION REQUEST; 60-DAY PUBLIC COMMENT REQUEST

WASHINGTON, May 21 -- Department Of Health And Human Services has issued a notice called: Agency Information Collection Request; 60-Day Public Comment Request. The notice was published in the Federal... Read More


DEPARTMENT OF HEALTH AND HUMAN SERVICES ISSUES NOTICE: AGENCY INFORMATION COLLECTION REQUEST; 60-DAY PUBLIC COMMENT REQUEST

WASHINGTON, May 21 -- Department Of Health And Human Services has issued a notice called: Agency Information Collection Request; 60-Day Public Comment Request. The notice was published in the Federal... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: REVOCATION OF EMERGENCY USE OF A DRUG PRODUCT DURING THE COVID-19 PANDEMIC; AVAILABILITY

WASHINGTON, May 21 -- Food and Drug Administration has issued a notice called: Revocation of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability. The notice was published in th... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: PRODUCT-SPECIFIC GUIDANCE ON FLUTICASONE PROPIONATE; DRAFT GUIDANCE FOR INDUSTRY; AVAILABILITY

WASHINGTON, May 21 -- Food and Drug Administration has issued a notice called: Product-Specific Guidance on Fluticasone Propionate; Draft Guidance for Industry; Availability. The notice was published... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: PRODUCT-SPECIFIC GUIDANCES; DRAFT AND REVISED DRAFT GUIDANCES FOR INDUSTRY; AVAILABILITY

WASHINGTON, May 21 -- Food and Drug Administration has issued a notice called: Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability. The notice was published in th... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: PRODUCT-SPECIFIC GUIDANCE ON ROFLUMILAST; DRAFT GUIDANCE FOR INDUSTRY; AVAILABILITY

WASHINGTON, May 21 -- Food and Drug Administration has issued a notice called: Product-Specific Guidance on Roflumilast; Draft Guidance for Industry; Availability. The notice was published in the Fed... Read More